Related Experiment Video
Updated: Jun 20, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
The cytokine network in chronic obstructive pulmonary disease
1National Heart and Lung Institute, Imperial College London, London, United Kingdom. p.j.barnes@imperial.ac.uk
American Journal of Respiratory Cell and Molecular Biology
|September 1, 2009
Summary
Cytokines orchestrate inflammation in airway diseases like chronic obstructive pulmonary disease (COPD). Broad anti-inflammatory strategies may be more effective than targeting single cytokines for COPD treatment.
Area of Science:
- Immunology
- Pulmonary Medicine
- Inflammation Research
Background:
- Cytokines, including lymphokines and chemokines, are key mediators in inflammatory airway diseases.
- These molecules regulate inflammatory cell recruitment, activation, survival, and structural changes in the airways.
- Chronic obstructive pulmonary disease (COPD) is characterized by complex cytokine-driven inflammation.
Purpose of the Study:
- To review the role of various cytokines in the pathogenesis of inflammatory airway diseases.
- To evaluate the therapeutic potential of targeting cytokine-mediated inflammation in COPD.
- To compare the efficacy of specific cytokine blockade versus broad anti-inflammatory approaches in COPD.
Main Methods:
- Literature review of studies on cytokine roles in inflammatory airway diseases.
- Analysis of therapeutic strategies targeting cytokine pathways in COPD.
- Synthesis of evidence regarding the clinical benefits of different anti-inflammatory approaches.
Main Results:
- Cytokines orchestrate multiple aspects of inflammation, including cell recruitment and survival in the airways.
- Growth factors contribute to sustained inflammation and structural remodeling in COPD.
- Targeting individual cytokines has shown limited clinical benefit in COPD.
Conclusions:
- Broad-spectrum anti-inflammatory approaches are likely more effective for treating COPD than blocking specific cytokines.
- Understanding the complex cytokine network is crucial for developing effective COPD therapies.
- Further research into comprehensive anti-inflammatory strategies is warranted for COPD management.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...